Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0335974B2 - - Google Patents
[go: Go Back, main page]

JPH0335974B2 - - Google Patents

Info

Publication number
JPH0335974B2
JPH0335974B2 JP59063284A JP6328484A JPH0335974B2 JP H0335974 B2 JPH0335974 B2 JP H0335974B2 JP 59063284 A JP59063284 A JP 59063284A JP 6328484 A JP6328484 A JP 6328484A JP H0335974 B2 JPH0335974 B2 JP H0335974B2
Authority
JP
Japan
Prior art keywords
polymyxin
fiber
group
adsorbent
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59063284A
Other languages
Japanese (ja)
Other versions
JPS60209525A (en
Inventor
Masatomo Kodama
Tooru Tani
Kazuyoshi Hanazawa
Fujitaro Oka
Kazuo Teramoto
Shiro Saikai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP59063284A priority Critical patent/JPS60209525A/en
Publication of JPS60209525A publication Critical patent/JPS60209525A/en
Publication of JPH0335974B2 publication Critical patent/JPH0335974B2/ja
Granted legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30Processes for preparing, regenerating, or reactivating
    • B01J20/32Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3244Non-macromolecular compounds
    • B01J20/3246Non-macromolecular compounds having a well defined chemical structure
    • B01J20/3248Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such
    • B01J20/3253Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such comprising a cyclic structure not containing any of the heteroatoms nitrogen, oxygen or sulfur, e.g. aromatic structures
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/28Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
    • B01J20/28014Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
    • B01J20/28023Fibres or filaments
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30Processes for preparing, regenerating, or reactivating
    • B01J20/32Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3202Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
    • B01J20/3206Organic carriers, supports or substrates
    • B01J20/3208Polymeric carriers, supports or substrates
    • B01J20/321Polymeric carriers, supports or substrates consisting of a polymer obtained by reactions involving only carbon to carbon unsaturated bonds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30Processes for preparing, regenerating, or reactivating
    • B01J20/32Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3244Non-macromolecular compounds
    • B01J20/3246Non-macromolecular compounds having a well defined chemical structure
    • B01J20/3248Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such
    • B01J20/3251Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such comprising at least two different types of heteroatoms selected from nitrogen, oxygen or sulphur

Landscapes

  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Description

【発明の詳細な説明】 (発明の技術分野) 本発明は、内毒素の解毒吸着剤に関する。 (従来技術とその問題点) 内毒素は、哺乳動物の血中に入ると発熱性と毒
性を示す物質である。これは、グラム陰性菌の細
胞壁外膜から由来するリポ多糖体である。典型的
なグラム陰性菌である大腸菌は腸内に常在する
が、健康なときは、その内毒素は吸収されても肝
臓で解毒されるので、血中に現れることはない。 しかし、肝機能の低下しているとき、制癌剤や
免疫抑制剤の投与を受けているとき、大きな火傷
が怪我を負つたとき、大きな外科手術を受けたと
きなどには重度の細菌感染症にかかりやすく、そ
の結果、内毒素血症となり、シヨツクを起すこと
がある。また肝膿瘍や胆嚢炎などのときにも、内
毒素血症となり、シヨツクを起すことがある。そ
のほか留置カテーテル、人工透析器具や輪液が内
毒素で汚染されていると、いきなり内毒素血症と
なり、シヨツクを起すことがある。大腸菌や緑膿
菌などで代表されるグラム陰性菌は一般に弱毒性
菌であるが、抗生物質が効きにくいものが多くな
つているため、細菌感染は大きな問題である。 内毒素は熱に安定な物質であり、高圧蒸気滅菌
でも解毒できない。イオン交換樹脂はこの内毒素
を非特異的に吸着するといわれているが、その容
量は小さいので、内毒素血症治療には有効でな
い。 内毒素を解毒する薬剤としてポリミキシンが知
られている。これは腸管非吸収性のヘプチド系抗
生物質であるが、中枢神経や腎に対する毒性が強
いので、経口投与あるいは局所投与に限られる。
したがつて、内毒素血症治療には直接使えない。 ポリミキシンをセフアロースに固定化したもの
は内毒素吸着剤として知られているが、膨潤性が
大きく機械的強度も低いため、内毒素血症治療に
は使えない。 固定化ポリミキシンの作用は内毒素の分解であ
ることが本発明で確認されたが、この場合、この
分解産物が別の毒作用を示す可能性が考えられ
る。 (発明の目的) 内毒素を解毒するとともに吸着除去することの
できる材料を作りだすこと。 (発明の構成) 不溶性ビニル重合体成形品に塩基性窒素原子を
有する官能基とポリミキシング分子を結合してな
る解毒吸着剤。 (構成の説明) 本発明でいう不溶性ビニル重合体成形品とは、
使用条件において、実質上、不溶性であるビニル
重合体であつて、塩基性窒素原子を有する官能基
を導入すること、および、ポリミキシン分子を共
有結合で結合することができ、かつ、繊維、中空
糸、膜および、それらの高次加工品を意味する。 本発明の不溶性ビニル重合体成形品がポリミキ
シン分子と共有結合で結合するためには、該重合
体にα−ハロゲン化アシル基、ハロゲン化アルキ
ル基、イソシアン酸基、カルボキシル基またはカ
ルボン酸エステル基等の官能基が重合体に直接ま
たはスペーサーを介して結合していることが必要
である。このスペーサーの長さはメチレン基にし
て4個以上の長さのあることが望ましい。 かかる不溶性ビニル重合体の例としては、スチ
レン、塩化ビニル、アクリル酸アミド、アクリロ
ニトリル、無水マレイン酸、メタクリル酸エステ
ルなどで代表されるモノビニル化合物の単独重合
体または共重合体、または、ジビニルベンゼンあ
るいはメチレンビスアクリルアミド等で代表され
るポリビニル化合物との共重合体のほか、上記モ
ノビニル化合物重合体成形品をホルムアルデヒ
ド、クロルスルホン酸等で架橋処理したもの等が
あげられる。架橋重合体は流動性がなく、成形が
困難なので、該重合体成形品が繊維、膜等の場合
は成形後架橋処理する方法が好ましく採用され
る。 本発明の成形品は、その表面積が大きくなるほ
ど内毒素の解毒吸着能力も大きくなるが、該成形
品を充填したカラムの通液性は逆に悪くなるの
で、該表面積は0.01以上100m2/g以下、より好
ましくは、0.05以上10m2/g以下がよい。 本発明でいう塩基性窒素原子を有する官能基と
は第1級アミノ基、モノメチルアミノアルキル
基、モノエチルアミノアルキル基、モノブチルア
ミノアルキル基等で代表される第2級アミノ基、
ジメチルアミノアルキル基、ジエチルアミノアル
キル基、ジn−プロピルアミノアルキル基、ジn
−ブチルアミノアルキル基等で代表される第3級
アミノ基およびトリメチルアンモニユウムアルキ
ル基、トリエチルアンモニユウムアルキル基、ト
リn−プロピルアンモニユウムアルキル基、トリ
n−ブチルアンモニユウムアルキル基等で代表さ
れる第4級アンモニユウム基を意味する。当該塩
基性窒素原子を有する官能基の密度は0.1ミリ当
量/g以上、より好ましくは、0.5ミリ当量/g
以上がよい。 塩基性窒素原子を有する官能基と不溶性ビニル
重合体とを結合する基は使用条件において安定な
ものであればよい。 本発明でいうポリミキシンとは、Bacillus
Polymyxaにより生産される抗生物質であり、ポ
リミキシンA、ポリミキシンB1、ポリミキシン
B2、ポリミキシンD、ポリミキシンE1、および、
ポリミキシンE2等のグラム陰性菌に対する抗菌
作用を有するものを意味する。ポリミキシン分子
と不溶性ビニル重合体との結合状態はポリミキシ
ン分子中のアミノ基がすべてアミド化されてしま
うと、内毒素に対する解毒活性がなくなるので、
少なくとも1個以上のアミノ基が塩基性基として
存在していなければならない。ポリミキシン分子
の存在密度は小さすぎると、内毒素に対する解毒
活性がなくなるので、成型品1gあたり1mg以
上、より好ましくは、20mg以上がよい。 ポリミキシン分子と不溶性ビニル重合体とを結
合する基の鎖長があまり短いと、内毒素に対する
ポリミキシンの解毒活性が発揮されないので、そ
の鎖長は炭素数にして4個以上であることが望ま
しい。 本発明解毒吸着剤の調製方法の代表例をあげる
と、成型品がホルムアルデヒド・N−メチロール
−α−クロルアセトアミド・硫酸処理によつて不
溶化とα−クロルアセトアミドメチル化を行つた
ポリスチレン繊維である場合、 (1) 成型品とポリミキシンとをPH7以上で反応さ
せたのち、アミンと反応させる方法、 (2) 成型品を第1級ジアミンと第2級アミンの混
合物で処理して、混合アミノ化し、さらに無水
コハク酸でサクシニル化したのち、ペプチド縮
合剤の存在下でポリミキシンと反応させる方法
がある。 本発明解毒吸着剤の用途は、輸液および透析液
中の内毒素除去のほか、留置カテーテル使用時の
感染予防、重度火傷時の感染予防、消化器や心臓
が脳等の手術後の内毒素血症予防、内毒素血症患
者の治療などがあり、その使用方法の代表例とし
て、当該解毒吸着剤を充填したカラムに輸液、透
析液または血液を循環させる方法、留置カテーテ
ルの外側に本発明解毒吸着剤を併置する方法、火
傷部の表面を本発明解毒吸着剤で被覆する方法等
がある。 (発明の作用機構) 本発明解毒吸着剤の作用機構はポリミキシン分
子基で内毒素を分解し、塩基性窒素原子を有する
官能基で内毒素の分解産物を吸着するものと考え
られる。 (発明の効果) 本発明の解毒吸着剤はポリミキシン分子基と塩
基性窒素原子を有する官能基を共有することによ
つて、内毒素を分解するとともに、その分解産物
を吸着除去するため、その使用効果が大きい特徴
がある。また、ポリミキシンの固定化密度が低く
ても、大きな効果が得られるので、高価なポリミ
キシンを節約できる特徴がある。 以下に実施例を示す。 実施例 1 ポリプロピレン(三井“ノーブレン”J3HG)
50部を島成分とし、ポリスチレン(“スタイロン”
666)46部、ポリプロピレン(住友“ノーブレン”
WF−727−F)4部の混合物を海成分とする海
島型複合繊維(島数16、単糸繊度2.6デニール、
引張強度2.9g/d、伸度50%、フイラメント数
42)50gを、N−メチロール−α−クロルアセト
アミド60g、ニトロベンゼン400g、98%硫酸400
gおよびパラホルムアルデヒド0.85gからなる混
合溶液中に浸し、20℃で1時間反応させた。繊維
を反応液から取り出し、0℃の氷水5中に投じ
て、反応停止させたのち、水で洗浄し、次に、繊
維に付着しているニトロベンゼンをメタノールで
抽出除去した。この繊維(繊維A)を50℃で真空
乾燥して、クロルアセトアミドメチル化繊維71g
を得た。 硫酸ポリミキシンB(シグマ社;8000単位/mg)
4.8gを600mlの水にとかし、この中に繊維A22g
を加え、5時間振とうしたのち、酸化マグネシウ
ム1.5gを添加し、室温で12時間振とうした。つ
ぎに、この繊維を反応母液から取り出し、クロマ
トカラムにつめて、0.1N−塩酸4800mlで洗浄し
て、ポリミキシン固定化繊維(繊維B)をえた。
この洗浄液と反応母液中のポリミキシン量をミク
ロビユレツト法で測定し、その量と仕込量との差
を繊維に固定化されたポリミキシン量ととみなし
た。固定化量は39mg/gであつた。 繊維B20gを50%ジメチルアミン水溶液に浸
し、55℃で4時間加熱した。この繊維を、順次、
水、1N−塩酸、水、0.17M−リン酸緩衝液(PH
7.4)で洗つて、本発明解毒吸着剤1をえた。本
発明解毒吸着剤中のアミノ基量は2.1ミリ当量/
gであつた。 実施例 2 1、12−ジアミノドデカン23.7gを1050mlの50
%ジメチルアミン水溶液に溶解してえた混合溶液
に実施例1で得られたクロルアセトアミドメチル
化繊維(繊維A)34gを加えて、72時間反応させ
た。繊維を取り出し、希塩酸、および水でよく洗
つて、混合アミノ化繊維(繊維C)をえた。繊維
Cの交換容量と無水酢酸/ピリジンでアセチル化
される量から、繊維中のジメチルアミノ基量は
2.27ミリモル/g、1、12−ジアミノドデカン量
は0.16ミリモル/gであつた。繊維C30gを1N−
カセイソーダ水溶液で処理したのち、十分に水洗
し、次に乾燥して、アミノ化繊維(繊維D)を得
た。 無水コハク酸6.0gを溶したDMSO400mlに23.4
gの繊維Dを浸し、50℃で5時間加熱したのち、
水洗してサクシニル化繊維(繊維E)をえた。 繊維E20g(乾重量)を250mlの硫酸ポリミキ
シンB(シグマ社製)水溶液(15mg/ml)中に浸
し、1N−カセイソーダ水溶液および1N−塩酸水
溶液で溶液のPHを4.5〜6.0に合せながら、1−エ
チル−3−(3−ジメチルアミノプロピル)カル
ボジイミド500mgを3時間かけて加えた。その後、
反応混合物を室温で5日間振とうした後、繊維を
クロマトカラムにつめて、水4で洗浄し、さら
に、リン酸緩衝液1で洗浄して本発明解毒吸着
剤2を得た。反応母液および洗浄液中のポリミキ
シン量をミクロビユレツト法で測定し、その量と
仕込量の差を繊維に固定化されたポリミキシン量
とみなした。 固定化密度は119mg/gであつた。 実施例 3 Escherichia Coli 055:B5のリポ多糖体(デ
イフコ・ラボラトリーズ社製、トリクロル酢酸抽
出法)100mgを200mlの生理食塩水に溶した溶液20
mlに2gの本発明吸着剤1または2を加え、37℃
で60分間振とう後、上澄を1mlずつICRマウスに
尾静脈から投与して、48時間後の死亡率を調べ
た。同じ上澄の中に含まれる糖成分の量をフエノ
ール・硫酸法(試料溶液1ml+5%フエノール水
1ml+濃硫酸5ml:485mμ)で求めた。また、同
じ上澄の中に含まれる内毒素量をトキシカラーテ
スト(生化学工業株式会社製)で調べた。 比較のために、本発明吸着剤の代りに繊維A、
繊維B、繊維Cおよびイオン交換樹脂IRA−938
について同様の実験を行つた。結果を表1に示
す。 表1からポリミキシン固定化繊維(繊維B)は
内毒素を分解するが、吸着はしないこと、および
アニオン交換繊維(繊維C)および樹脂は糖成分
を吸着するがマウス死亡率はさがらないこと、両
官能基が共存する本発明吸着剤が解毒と吸着の両
方の作用を有することがわかる。 【表】
TECHNICAL FIELD OF THE INVENTION The present invention relates to endotoxin detoxification adsorbents. (Prior art and its problems) Endotoxin is a substance that exhibits pyrogenicity and toxicity when it enters the blood of mammals. It is a lipopolysaccharide derived from the outer cell wall membrane of Gram-negative bacteria. Escherichia coli, a typical gram-negative bacterium, always resides in the intestines, but when the body is healthy, its endotoxins are detoxified by the liver even if absorbed, so they do not appear in the blood. However, if your liver function is impaired, if you are receiving anticancer drugs or immunosuppressive drugs, if you have a large burn injury, or if you have undergone major surgery, you may be susceptible to severe bacterial infections. This can result in endotoxemia and shock. In addition, endotoxemia may occur in cases of liver abscess or cholecystitis, which may lead to shock. In addition, if an indwelling catheter, dialysis equipment, or circulatory fluid is contaminated with endotoxin, endotoxemia may suddenly occur, which may cause a shock. Gram-negative bacteria, such as Escherichia coli and Pseudomonas aeruginosa, are generally weakly virulent bacteria, but bacterial infections are a major problem because antibiotics are becoming increasingly resistant to them. Endotoxins are heat-stable substances and cannot be detoxified by autoclaving. Ion-exchange resins are said to non-specifically adsorb endotoxins, but their capacity is small, so they are not effective in treating endotoxemia. Polymyxin is known as a drug that detoxifies endotoxins. This is a heptide antibiotic that is not absorbed in the intestinal tract, but it is highly toxic to the central nervous system and kidneys, so it can only be administered orally or locally.
Therefore, it cannot be used directly to treat endotoxemia. Polymyxin immobilized on sepharose is known as an endotoxin adsorbent, but it cannot be used to treat endotoxemia because it has high swelling properties and low mechanical strength. Although it has been confirmed in the present invention that the action of immobilized polymyxin is the decomposition of endotoxin, in this case, it is possible that this decomposition product exhibits other toxic effects. (Objective of the invention) To create a material that can detoxify and adsorb and remove endotoxins. (Structure of the Invention) A detoxification adsorbent formed by bonding a functional group having a basic nitrogen atom and a polymixing molecule to an insoluble vinyl polymer molded article. (Explanation of structure) The insoluble vinyl polymer molded article in the present invention is
A vinyl polymer that is substantially insoluble under the conditions of use, into which a functional group having a basic nitrogen atom can be introduced, and to which polymyxin molecules can be covalently bonded, and which is suitable for fibers and hollow fibers. , membranes and their highly processed products. In order for the insoluble vinyl polymer molded article of the present invention to covalently bond to a polymyxin molecule, the polymer must include an α-halogenated acyl group, a halogenated alkyl group, an isocyanate group, a carboxyl group, or a carboxylic acid ester group. It is necessary that the functional group is bonded to the polymer directly or via a spacer. The length of this spacer is preferably 4 or more methylene groups. Examples of such insoluble vinyl polymers include homopolymers or copolymers of monovinyl compounds represented by styrene, vinyl chloride, acrylic amide, acrylonitrile, maleic anhydride, methacrylic esters, or divinylbenzene or methylene. In addition to copolymers with polyvinyl compounds such as bisacrylamide, examples include those obtained by crosslinking the monovinyl compound polymer molded products with formaldehyde, chlorosulfonic acid, and the like. Crosslinked polymers have no fluidity and are difficult to mold, so when the polymer molded product is a fiber, membrane, etc., a method of crosslinking after molding is preferably employed. The greater the surface area of the molded article of the present invention, the greater its ability to detoxify and adsorb endotoxins; however, the liquid permeability of a column filled with the molded article becomes worse, so the surface area should be 0.01 or more and 100 m 2 /g. More preferably, it is 0.05 or more and 10 m 2 /g or less. In the present invention, the functional group having a basic nitrogen atom is a secondary amino group represented by a primary amino group, a monomethylaminoalkyl group, a monoethylaminoalkyl group, a monobutylaminoalkyl group, etc.
dimethylaminoalkyl group, diethylaminoalkyl group, di-n-propylaminoalkyl group, di-n
- Tertiary amino groups represented by butylaminoalkyl groups, etc.; and tertiary amino groups represented by trimethylammonium alkyl groups, triethylammonium alkyl groups, tri-n-propylammonium alkyl groups, tri-n-butylammonium alkyl groups, etc. It means a quaternary ammonium group. The density of the functional group having a basic nitrogen atom is 0.1 meq/g or more, more preferably 0.5 meq/g.
The above is good. The group that connects the functional group having a basic nitrogen atom and the insoluble vinyl polymer may be any group that is stable under the conditions of use. Polymyxin as used in the present invention refers to Bacillus
It is an antibiotic produced by Polymyxa, including polymyxin A, polymyxin B 1 , polymyxin
B 2 , polymyxin D, polymyxin E 1 , and
Refers to substances that have antibacterial activity against Gram-negative bacteria such as polymyxin E 2 . The bonding state between the polymyxin molecule and the insoluble vinyl polymer is such that when all the amino groups in the polymyxin molecule are amidated, the detoxifying activity against endotoxins is lost.
At least one amino group must be present as a basic group. If the density of polymyxin molecules is too low, there will be no detoxifying activity against endotoxins, so it is preferably 1 mg or more, more preferably 20 mg or more per gram of molded product. If the chain length of the group that binds the polymyxin molecule and the insoluble vinyl polymer is too short, the detoxifying activity of polymyxin against endotoxins will not be exhibited, so the chain length is preferably 4 or more carbon atoms. A typical example of the method for preparing the detoxifying adsorbent of the present invention is when the molded product is a polystyrene fiber that has been insolubilized and α-chloroacetamide methylated by formaldehyde/N-methylol-α-chloroacetamide/sulfuric acid treatment. (1) A method in which the molded product is reacted with polymyxin at a pH of 7 or higher and then reacted with an amine; (2) The molded product is treated with a mixture of a primary diamine and a secondary amine to perform mixed amination; Furthermore, there is a method of succinylating with succinic anhydride and then reacting with polymyxin in the presence of a peptide condensing agent. The detoxification adsorbent of the present invention can be used to remove endotoxins from transfusions and dialysis fluids, as well as to prevent infection when using an indwelling catheter, to prevent infection during severe burns, and to prevent endotoxin blood loss after surgery for the digestive tract, heart, brain, etc. Typical examples of its use include circulating infusion fluid, dialysate, or blood through a column filled with the detoxification adsorbent, and placing the detoxification agent of the present invention on the outside of an indwelling catheter. There are methods such as placing an adsorbent in parallel, and coating the surface of the burn area with the detoxifying adsorbent of the present invention. (Mechanism of action of the invention) The action mechanism of the detoxification adsorbent of the present invention is considered to be that the polymyxin molecular group decomposes endotoxin, and the functional group having a basic nitrogen atom adsorbs the decomposition products of endotoxin. (Effects of the Invention) The detoxification adsorbent of the present invention shares a polymyxin molecular group with a functional group having a basic nitrogen atom, thereby decomposing endotoxins and adsorbing and removing the decomposition products. It has features that are highly effective. Furthermore, even if the immobilization density of polymyxin is low, a large effect can be obtained, so that expensive polymyxin can be saved. Examples are shown below. Example 1 Polypropylene (Mitsui “Noblen” J3HG)
50 parts as an island component, polystyrene (“Styron”)
666) 46 parts, polypropylene (Sumitomo “Noblen”)
Sea-island composite fiber containing 4 parts of WF-727-F) as sea component (number of islands: 16, single yarn fineness: 2.6 denier,
Tensile strength 2.9g/d, elongation 50%, number of filaments
42) 50g, N-methylol-α-chloroacetamide 60g, nitrobenzene 400g, 98% sulfuric acid 400g
g and 0.85 g of paraformaldehyde, and reacted at 20° C. for 1 hour. The fibers were taken out from the reaction solution and poured into ice water 5 at 0° C. to stop the reaction, washed with water, and then the nitrobenzene adhering to the fibers was extracted and removed with methanol. This fiber (fiber A) was vacuum dried at 50°C, and 71g of chloroacetamide methylated fiber was obtained.
I got it. Polymyxin B sulfate (Sigma; 8000 units/mg)
Dissolve 4.8g in 600ml of water and add 22g of fiber A in this.
After shaking for 5 hours, 1.5 g of magnesium oxide was added and shaking at room temperature for 12 hours. Next, this fiber was taken out from the reaction mother liquor, packed into a chromatography column, and washed with 4800 ml of 0.1N hydrochloric acid to obtain a polymyxin-immobilized fiber (fiber B).
The amount of polymyxin in this washing solution and the reaction mother liquor was measured by the microbiuret method, and the difference between the measured amount and the amount charged was regarded as the amount of polymyxin immobilized on the fibers. The immobilized amount was 39 mg/g. 20 g of fiber B was immersed in a 50% dimethylamine aqueous solution and heated at 55° C. for 4 hours. This fiber is sequentially
Water, 1N-hydrochloric acid, water, 0.17M-phosphate buffer (PH
7.4) to obtain the detoxifying adsorbent 1 of the present invention. The amount of amino groups in the detoxification adsorbent of the present invention is 2.1 milliequivalent/
It was hot at g. Example 2 23.7 g of 1,12-diaminododecane was added to 1050 ml of 50
34 g of the chloroacetamidomethylated fiber (fiber A) obtained in Example 1 was added to a mixed solution obtained by dissolving the fiber in a % dimethylamine aqueous solution, and the mixture was reacted for 72 hours. The fibers were taken out and thoroughly washed with dilute hydrochloric acid and water to obtain mixed aminated fibers (fiber C). From the exchange capacity of fiber C and the amount acetylated with acetic anhydride/pyridine, the amount of dimethylamino groups in the fiber is
The amount of 1,12-diaminododecane was 0.16 mmol/g. 1N-30g of fiber C
After being treated with a caustic soda aqueous solution, the fibers were thoroughly washed with water and then dried to obtain aminated fibers (fibers D). 23.4 in DMSO400ml containing 6.0g of succinic anhydride
After soaking g of fiber D and heating it at 50℃ for 5 hours,
A succinylated fiber (fiber E) was obtained by washing with water. 20 g (dry weight) of fiber E was immersed in 250 ml of sulfuric acid polymyxin B (manufactured by Sigma) aqueous solution (15 mg/ml), and while adjusting the pH of the solution to 4.5 to 6.0 with 1N caustic soda aqueous solution and 1N hydrochloric acid aqueous solution, 1- 500 mg of ethyl-3-(3-dimethylaminopropyl)carbodiimide was added over 3 hours. after that,
After shaking the reaction mixture at room temperature for 5 days, the fibers were packed into a chromatography column and washed with 4 portions of water and 1 portion of phosphate buffer to obtain detoxifying adsorbent 2 of the present invention. The amount of polymyxin in the reaction mother liquor and washing solution was measured by the microbiuret method, and the difference between that amount and the amount charged was regarded as the amount of polymyxin immobilized on the fibers. The immobilization density was 119 mg/g. Example 3 Escherichia Coli 055: A solution of 100 mg of B5 lipopolysaccharide (manufactured by Difco Laboratories, trichloroacetic acid extraction method) dissolved in 200 ml of physiological saline 20
Add 2g of adsorbent 1 or 2 of the present invention to ml and heat at 37°C.
After shaking for 60 minutes, 1 ml of the supernatant was administered to ICR mice via the tail vein, and the mortality rate was examined 48 hours later. The amount of sugar components contained in the same supernatant was determined by the phenol/sulfuric acid method (1 ml of sample solution + 1 ml of 5% phenol water + 5 ml of concentrated sulfuric acid: 485 mμ). In addition, the amount of endotoxin contained in the same supernatant was examined using a Toxicolor Test (manufactured by Seikagaku Corporation). For comparison, fiber A, instead of the adsorbent of the present invention,
Fiber B, Fiber C and ion exchange resin IRA-938
A similar experiment was conducted for The results are shown in Table 1. Table 1 shows that polymyxin-immobilized fibers (fiber B) degrade endotoxins but do not adsorb them, and that anion exchange fibers (fiber C) and resins adsorb sugar components but do not reduce mouse mortality. It can be seen that the adsorbent of the present invention in which functional groups coexist has both detoxification and adsorption effects. 【table】

Claims (1)

【特許請求の範囲】[Claims] 1 不溶性ビニル重合体成形品に塩基性窒素原子
を有する官能基とポリミキシン分子を結合してな
る解毒吸着剤。
1. A detoxification adsorbent made by bonding a functional group having a basic nitrogen atom and a polymyxin molecule to an insoluble vinyl polymer molded article.
JP59063284A 1984-04-02 1984-04-02 Alexeteric adsorbent for endotoxin Granted JPS60209525A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59063284A JPS60209525A (en) 1984-04-02 1984-04-02 Alexeteric adsorbent for endotoxin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59063284A JPS60209525A (en) 1984-04-02 1984-04-02 Alexeteric adsorbent for endotoxin

Publications (2)

Publication Number Publication Date
JPS60209525A JPS60209525A (en) 1985-10-22
JPH0335974B2 true JPH0335974B2 (en) 1991-05-30

Family

ID=13224869

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59063284A Granted JPS60209525A (en) 1984-04-02 1984-04-02 Alexeteric adsorbent for endotoxin

Country Status (1)

Country Link
JP (1) JPS60209525A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012133609A1 (en) 2011-03-30 2012-10-04 東レ株式会社 Blood-purifying column

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12020552032B1 (en) 2018-07-31 2023-09-15 Toray Industries Carrier for adsorbing organic matter
US20240352665A1 (en) 2021-07-29 2024-10-24 Japan Hemotech Co., Ltd. Nonwoven substrate, fibrous material for liquid clarifiction, production method for said material, and cleaner equipped with said material

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012133609A1 (en) 2011-03-30 2012-10-04 東レ株式会社 Blood-purifying column

Also Published As

Publication number Publication date
JPS60209525A (en) 1985-10-22

Similar Documents

Publication Publication Date Title
US4661260A (en) Endotoxin detoxifying process
US5679775A (en) Process and device for the simultaneous extracorporeal elimination of tumour necrosis factor and bacterial lipopolysaccharides from whole blood and/or blood plasma
JPH0567305B2 (en)
US5136032A (en) Method for separating phosphopolyol compounds using a separating agent
US20090211976A1 (en) Device for removing bacterial lipopolysaccharides and/or lipoteichoic acids from protein-containing fluids and its use for the treatment of sepsis
WO2000037172A1 (en) Materials for removing bacterial components
HU226017B1 (en) Patient-specific immunoadsorbents for extracorporal apheresis and methods of producing said immuno-adsorbers
DE102006055558A1 (en) Adsorbent for removing endotoxins from solutions comprises a ligand in the form of an amine-functional molecule in which some of the amine groups are modified with an amine-reactive molecule
JP3926573B2 (en) Adsorbent manufacturing method for reducing the concentration of fibrinogen and / or fibrin, adsorbent and use of the adsorbent for the manufacture of an adsorber
JPH0116389B2 (en)
JPH0335974B2 (en)
JPH0518625B2 (en)
EP0107119B1 (en) Blood-treating material
KR100978169B1 (en) Immunosuppressant Adsorbents, Extracorporeal Circulation Columns and Cancer Treatment Methods
JPH067430A (en) Blood treating adsorbent
JPH0526507B2 (en)
JP2002113097A (en) Adsorbents and extracorporeal circulation columns
EP2753425B1 (en) Use of modified hollow fiber materials for removing exotoxins produced by escherichia coli from blood and plasma
JP2000237585A (en) Medical adsorption material
JP4779190B2 (en) Inflammatory disease treatment column
JPH06237996A (en) Blood purifying/adsorbing material
JPH07816A (en) Endotoxin adsorbent
JP4848573B2 (en) Methods for removing or detoxifying free lipoteichoic acid from liquids
JP4505950B2 (en) Adsorbent and extracorporeal circulation column
JPH06233816A (en) Hemocatharsis adsorbent

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term